Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Scientists can control how skin stem cells divide by using different treatments.

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

Dutasteride may reduce insulin sensitivity and increase body fat.

The protein aPKCλ is crucial for keeping hair follicle stem cells inactive and for hair growth and regeneration.

Relatives of lupus patients show signs of immune system activity but not full-blown lupus.

Wnt signaling is important for development and cell regulation but can cause diseases like cancer when not working properly.

A woman's hair turned white after taking a cancer drug called dasatinib.

Foreign-body granuloma may be a marker for late-stage Lichen Planopilaris and should be considered in diagnosis.

Using defensins to activate stem cells may improve skin aging signs without causing inflammation.

Spironolactone might lower the chance of getting rosacea.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

PAK4 is crucial in cancer progression, brain development, and could be a therapeutic target, especially through the PAK4-CREB axis.

Stem cells have great potential for improving wound healing, but more research is needed to find the best types and ways to use them.

Microneedles help treat hair loss by improving hair surroundings and promoting growth.

The mTOR pathway proteins are altered in the hair follicles of patients with Lichen Planopilaris and Frontal Fibrosing Alopecia.

Glycemic control medications for Type 2 diabetes can affect skin conditions like psoriasis.

A new microneedle patch helps repair spinal cord injuries by reducing scarring and promoting nerve growth.

Ayurvedic treatment can reverse premature graying and improve hair health.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

Differences in growth factors in platelet-rich plasma therapy for hair loss can vary between patients and can be influenced by the devices used, possibly leading to inconsistent results.

UV radiation may cause DNA changes in skin, certain UVB therapy helps psoriasis, a new gene mutation is linked to mild piebaldism, different immune cells affect psoriasis, a drug promotes hair growth, and some cancer drugs could treat skin barrier issues.

Dermagraft and Dermalogen had a lot of granulation, while Alloderm, Integra, and ADM had good blood vessel growth for skin healing.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

New drug uses show promise but need more research.

Hair cortisol may be a good indicator of recent mood in people with bipolar disorder.